TERRY BECKER: Open Payments
NPI 1447334214 · KEARNEY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$189 in 6 payments from 5 companies in 2025. Trend: 2023 $342 · 2024 $186 · 2025 $189
Food & beverage: $189
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $93 |
| Novo Nordisk Inc | 2 | $32 |
| Astellas Pharma US Inc | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Lundbeck LLC | 1 | $14 |
Products named: VRAYLAR, REXULTI, Veozah, Rybelsus, Ozempic.
Industry payments across NE — which companies pay providers there.
